A multicenter collaboration leaded by the Bellvitge Biomedical Research Institute (IDIBELL), the Catalan Institute of Oncology (ICO) and the Germans Trias i Pujol Research Institute (IGTP) identified a potential new treatment for an aggressive sarcoma arising in the nerves. The findings have been published in the journal Clinical Cancer Research.
The conference fostered interactions between both research areas to generate new synergies and nurture existing ones.
The study underscores the importance of increasing vaccination in adults to prevent invasive pneumococcal disease, especially in risk groups (older adults and/or those with comorbidities).
There is a need to continue developing and improving pneumococcal vaccines to expand their coverage, given the great capacity of these pathogens to adapt.
IDIBELL researchers identify key factors in Ewing’s sarcoma metastasis
Step forward in the understanding of Ewing sarcoma Read More »
Two IDIBELL researchers receive financial support to consolidate and enhance the internationalization of their research
This large-scale nutrimetabolomic analysis, one of the most extensive to date, underscores the relevance of dietary factors and the gut microbiome in prostate cancer risk.
The study has been led by the Bellvitge Biomedical Research Institute (IDIBELL), the University of Barcelona and the CIBER on Frailty and Healthy Ageing (CIBERFES).
A Bellvitge research team has conducted a randomized clinical trial in hematological patients with febrile neutropenia to assess the efficacy of extended infusion of beta-lactam antibiotics
The results show that extended perfusion may be useful in combating some infections, but do not support the introduction of this technique into daily clinical practice for the empirical treatment of febrile neutropenia.
They have described a cause why kidney progenitor cells sometimes can’t repair damaged tissues
The study has been published in the American Journal of Transplantation, the journal with the highest impact on transplantation
XarSMART plays the role of a valorization and transfer network, and works to increase the market value of Personalized Precision Medicine, digital health and biomedical data science projects.
IDIBELL organizes the II Assembly of XarSMART Read More »
An intellectually stimulating lifestyle has been shown to reduce the severity of cognitive deficits and delay disease progression in Huntington’s disease patients. Now, a new study led by IDIBELL researchers shows that these positive effects may also have a direct transfer to motor and psychiatric domains of the disease, not only cognitive.
An intellectually stimulating lifestyle is key to fighting Huntington’s disease Read More »
